Logo
Logo
LOGIN
SUBSCRIBE
EXPERIENCE PSILOCYBIN
INTEGRATE YOUR JOURNEY
SHOP MERCH
ARCHIVE
Logo
Logo

BACK ISSUES

This Week in Psychedelics

Our flagship Wednesday newsletter breaks down the latest and greatest updates across psychedelic research, policy, and business. It’s serious psychedelic news, delivered with personality… and memes. Gotta have the memes.

READ MORE

Ask a Guide Anything

Every Friday, we source one burning question directly from you, dear readers, and pitch it to our network of vetted psychedelic practitioners. There are no stupid questions, but we do love a good brain buster.

READ MORE

Psychonaut POV

On Sundays, we spotlight a luminary in the psychedelic field with a feature interview. It could be a clinician, a researcher, an entrepreneur, an advocate… variety is the spice of life. These pioneers don’t all always agree, and that’s part of what makes the series great.

READ MORE

ARCHIVE

🫠 Psychonaut POV

Oct 8, 2023

🫠 Psychonaut POV

[7-min read] Q&A with Reid Robison, Chief Clinical Officer

Henry Winslow
Henry Winslow
🫠 This Week in Psychedelics

Oct 4, 2023

🫠 This Week in Psychedelics

[5-min read] FDA accepts PharmaTher’s NDA for KETARX.

Henry Winslow
Henry Winslow
🫠 Psychonaut POV

Oct 1, 2023

🫠 Psychonaut POV

[5-min read] Q&A with Azalea Montaño-Kemp

Henry Winslow
Henry Winslow
🫠 This Week in Psychedelics

Sep 27, 2023

🫠 This Week in Psychedelics

[5-min read] Research on naturalistic psilocybin use shows lasting benefits.

Henry Winslow
Henry Winslow
🫠 Psychonaut POV

Sep 24, 2023

🫠 Psychonaut POV

[6-min read] Q&A with Kate Kincaid, Therapist & Mother

Henry Winslow
Henry Winslow
🫠 This Week in Psychedelics

Sep 20, 2023

🫠 This Week in Psychedelics

[5-min read] MAPS’ latest clinical trial paves the way for FDA approval.

Henry Winslow
Henry Winslow
🫠 Psychonaut POV

Sep 17, 2023

🫠 Psychonaut POV

[6-min read] Q&A with Raad Seraj, Angel Investor & Founder

Henry Winslow
Henry Winslow
🫠 This Week in Psychedelics

Sep 13, 2023

🫠 This Week in Psychedelics

[5-min read] AI model accurately predicts psilocybin treatment responses.

Henry Winslow
Henry Winslow
🫠 Psychonaut POV

Sep 10, 2023

🫠 Psychonaut POV

[6-min read] Q&A with Julian Vayne, Occultist & Scholar

Henry Winslow
Henry Winslow
🫠 This Week in Psychedelics

Sep 6, 2023

🫠 This Week in Psychedelics

[5-min read] One dose of psilocybin relieves depression for weeks in Usona trial.

Henry Winslow
Henry Winslow
🫠 Psychonaut POV

Sep 3, 2023

🫠 Psychonaut POV

[6-min read] Q&A with Wilhelmina De Castro, Therapist & Founder

Henry Winslow
Henry Winslow
🫠 This Week in Psychedelics

Aug 30, 2023

🫠 This Week in Psychedelics

[5-min read] Study suggests MDMA buffers against “bad trips” on psilocybin or LSD.

Henry Winslow
Henry Winslow
🫠 Psychonaut POV

Aug 27, 2023

🫠 Psychonaut POV

[6-min read] Q&A with Hunt Priest, Episcopal Priest & Director

Henry Winslow
Henry Winslow
🫠 This Week in Psychedelics

Aug 23, 2023

🫠 This Week in Psychedelics

[5-min read] Presidential candidates speak out on psychedelic policy reform.

Henry Winslow
Henry Winslow
🫠 Psychonaut POV

Aug 20, 2023

🫠 Psychonaut POV

[5-min read] Q&A with Ian-Michael Hébert, Eco Resort Developer

Henry Winslow
Henry Winslow
LOAD MORE

Stay ahead of the psychedelic movement. Industry news and practical wisdom, with a side of spicy memes. 🫠

I consent to receive newsletters via email. Terms of use and Privacy policy.

EXPERIENCE PSILOCYBIN

INTEGRATE YOUR JOURNEY

SHOP MERCH

archive

© 2026 Tricycle Day.
beehiivPowered by beehiiv